Belfast, United Kingdom
CRISM Therapeutics Corporation is a UK-based pharmaceutical company which has developed an innovative drug delivery technology, ChemoSeed, to improve the clinical performance of cancer treatments for solid tumours through the local delivery of chemotherapy. ChemoSeed will initially be used to treat glioblastoma, a brain tumour with no satisfactory treatment.
No key contacts have been added to this profile yet.
No reviews have been added to this profile yet.
This is the company profile page for CRISM Therapeutics on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.
